Sular and Dehydration - a phase IV clinical study of FDA data

Summary:

Dehydration is reported as a side effect among people who take Sular (nisoldipine), especially for people who are female, 60+ old, also take Digoxin, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Dehydration when taking Sular. It is created by eHealthMe based on reports of 1,710 people who have side effects when taking Sular from the FDA, and is updated regularly.

What is Sular?

Sular has active ingredients of nisoldipine. It is often used in high blood pressure. eHealthMe is studying from 1,757 Sular users. Check the latest studies of Sular.

What is Dehydration?

Dehydration (dryness resulting from the removal of water) is found to be associated with 2,771 drugs and 3,348 conditions by eHealthMe. Check the latest studies of Dehydration.

On Apr, 10, 2026

1,710 people reported to have side effects when taking Sular.
Among them, 28 people (1.64%) have Dehydration.

Among these 28 people:

What is the gender of people who have Dehydration when taking Sular? *

female: 74.07 %
male: 25.93 %

What is the age of people who have Dehydration when taking Sular? *

What are other drugs people take besides Sular? *

What are other side effects people have besides Dehydration? *

Nausea (feeling of having an urge to vomit): 12 people, 42.86%
Weakness: 9 people, 32.14%
Pneumonia: 8 people, 28.57%
Urinary Tract Infection: 7 people, 25.00%
Injury: 7 people, 25.00%
Nausea And Vomiting: 7 people, 25.00%
Fever: 7 people, 25.00%
Atelectasis (partial or complete collapse of the lung): 6 people, 21.43%
Anaemia (lack of blood): 6 people, 21.43%
Diarrhea: 6 people, 21.43%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 10.71%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 7.14%
Anaemia Haemolytic Autoimmune (a condition in which the immune system attacks the red blood cells, resulting in fewer of these oxygen-transporting cells): 2 people, 7.14%
Thyroid Diseases: 1 person, 3.57%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 3.57%
Stress And Anxiety: 1 person, 3.57%
Sleep Disorder: 1 person, 3.57%
Partial Seizures (seizures which affect only a part of the brain at onset): 1 person, 3.57%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 3.57%
Multiple Myeloma (cancer of the plasma cells): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Sular and have Dehydration?

- Check whether Dehydration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sular:

Sular (1,757 reports)

Dehydration treatments and more:

Dehydration (173,274 reports)

Browse all side effects of Sular:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dehydration:

Dehydration (2,771 drugs)

Browse all the conditions that are associated with Dehydration:

Dehydration (3,348 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nisoldipine (the active ingredients of Sular) and Sular (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.